Ignite Creation Date:
2024-05-06 @ 1:32 PM
Last Modification Date:
2024-10-26 @ 1:15 PM
Study NCT ID:
NCT04051944
Status:
COMPLETED
Last Update Posted:
2022-11-03
First Post:
2019-08-08
Brief Title:
A Study to Assess Long-term Safety Tolerability and Efficacy of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Sponsor:
UCB Biopharma SRL
Organization:
UCB Pharma
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-08-21
Start Date Type:
ACTUAL
Primary Completion Date:
2021-11-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-11-10
Completion Date Type:
ACTUAL
First Submit Date:
2019-08-08
First Submit QC Date:
August 8 2019
Study First Post Date:
2019-08-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2022-11-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-10-06
Last Update Post Date:
2022-11-03
Last Update Post Date Type:
ACTUAL